[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hla-sensitization":3},{"name":4,"total":5,"trials":6,"biomarkers":15,"states":16},"HLA Sensitization",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05300451","Daratumumab in HLA Desensitization Prior to Transplantation",[11],"Phase 2","ENROLLING_BY_INVITATION","2026-08-03T02:02:51.511154Z","2026-06-16T05:54:08.030025Z",[],[]]